Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine.

doi:10.1016/j.phymed.2021.153574

Paper

Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine.

Published Apr 15, 2021 · Y. Y. Jung, J. Um, Omaima Nasif

Phytomedicine : international journal of phytotherapy and phytopharmacology

Q1 SJR score

12

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Rigorous Journal

Study Snapshot

Leelamine can block STAT3 signaling in multiple myeloma cells, potentially reducing growth and survival when combined with approved anti-cancer agents.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine.

References

Citations